Seattle, WA, United States of America

Wayne R Kindsvogel

USPTO Granted Patents = 104 

 

 

Average Co-Inventor Count = 3.7

ph-index = 18

Forward Citations = 1,323(Granted Patents)


Inventors with similar research interests:


Company Filing History:


Years Active: 1991-2024

Loading Chart...
Loading Chart...
Loading Chart...
104 patents (USPTO):Explore Patents

Title: Wayne R. Kindsvogel: Innovator in Immunology

Introduction

Wayne R. Kindsvogel is a prominent inventor based in Seattle, WA, known for his remarkable contributions to the field of immunology. With a total of 104 patents to his name, he has significantly advanced the understanding and application of B lymphocyte cell lines in producing immunoglobulins. His innovative approaches have had a considerable impact on therapeutic methods in immunology.

Latest Patents

Among his latest patents, two stand out due to their groundbreaking methodologies. The first patent, titled "Compositions and methods for modified B cells expressing reassigned biological agents," focuses on producing one or more immunoglobulins in an isolated cytotoxic B lymphocyte cell line. It describes an isolated cell line capable of expressing at least one exogenously incorporated membrane immunoglobulin that binds to a first antigen, alongside an endogenous secreted immunoglobulin that binds to a second antigen. Additionally, it outlines the capability to express an exogenous recombinant B cell receptor, which signals for the expression of cytotoxic effector molecules.

The second patent, "Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulin," delves into similar techniques for producing immunoglobulins. This patent again highlights an isolated B lymphocyte cell line that can express an exogenous membrane immunoglobulin reactive to a first antigen, along with an endogenous secreted immunoglobulin reactive to a second antigen.

Career Highlights

Wayne's professional journey has included significant roles in reputable companies such as Zymogenetics, Inc. and Elwha LLC. His work at these companies has allowed him to pioneer advancements in biological research and product development.

Collaborations

Throughout his career, Wayne R. Kindsvogel has collaborated with skilled professionals, including Roderick A. Hyde and Wenfeng Xu. These partnerships have led to the successful development and patenting of innovative methods and compositions in immunology.

Conclusion

Wayne R. Kindsvogel continues to be a driving force in the field of immunology, leveraging his expertise to explore new horizons in therapeutic development. With a wealth of patents and ongoing collaborations, he is poised to influence the future of immunotherapy and biological research significantly. His work serves as an inspiration for aspiring inventors and researchers in the domain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…